EEG: Reinforcement Learning in Parkinson's
…week, either ON or OFF medication. CTL only came in once. Task…
- Participants
- 56
- Channels
- 67 (10-10)
- Citations
- 2
- Size
- 16.2 GB
- Version
- v1.0.0
- Updated
- Jun 22, 2026
…week, either ON or OFF medication. CTL only came in once. Task…
…with (MedOn) and without (MedOn) dopaminergic medication. It has two movement conditions…
Resting-state EEG recorded from 25 patients with Parkinson's disease enrolled in a double-blind, randomized, placebo-controlled trial of Neuroepo, an EPO formulation with low sialic acid content. Recordings were acquired before and six months after drug or placebo administration (Neuroepo n=15, placebo n=10). The raw data are shared in EEG-BIDS format to support evaluation of neuroprotective effects and qEEG biomarkers of disease progression.
…week, either ON or OFF medication. CTL only came in once. Task…
Resting-state EEG recorded from 25 patients with Parkinson's disease enrolled in a double-blind, randomized, placebo-controlled trial of Neuroepo, an erythropoietin formulation with low sialic acid content. Participants received Neuroepo (n=15) or placebo (n=10), and EEG was recorded before and six months after administration. Raw data are provided in EEG-BIDS format to support assessment of qualitative and quantitative EEG (source-level) biomarkers of neuroprotection.
…week, either ON or OFF medication. CTL only came in once. Task…
…one on and one off dopaminergic medication). Placed at the root so…
…of Socioeconomic Status, Medications - Chlorpromazine equivalency of prescribed medication at time of…
…of Socioeconomic Status, Medications - Chlorpromazine equivalency of prescribed medication at time of…
…metabolism and pathways relevant to dopaminergic vulnerability, suggesting a plausible route by…